For 25 years, Genesys Capital has been one of Canada’s leading early-stage venture firms dedicated to life sciences. With funds across multiple vintages and a growing LP base of institutional investors, family offices, and high-net-worth individuals, the firm has built its reputation on technical excellence and transparent stewardship.
But reporting life sciences investments — especially across complex scientific and financial dimensions — creates unique challenges:
Not all LPs have a background in biotech
Many require tailored communication
And as fund complexity grew, so did the cost of manual reporting
The Challenge of Reporting in Life Sciences VC
Genesys Capital is one of Canada’s leading early-stage venture capital firms focused on life sciences. With a 25-year track record, the team has built deep credibility among institutional investors, family offices, and high-net-worth LPs.
But as the firm scaled to four active funds, reporting became increasingly complex:
LPs had different preferences (tax, deal, IR contacts)
Email-based workflows led to missed updates and duplication
The biotech sector required added explanation for non-technical LPs
This wasn’t just an operational problem. It was a threat to the LP experience Genesys had worked hard to build.
The turning point
As the fourth fund launched, Jennifer knew something had to change. The volume of reporting, the rise in special LP requests, and the need for clarity — especially in a technically complex sector — made legacy methods unsustainable.
Through a trusted advisor and peer firm reference, Genesys discovered Vessel.
What Vessel Unlocked for Genesys
Vessel transformed the firm’s investor relations in four key ways:
Reporting became scalable: Instead of manually sorting contacts and reports, Jennifer’s team now uploads once and tags by LP role (IR, tax, legal).
Engagement became self-serve: LPs log into a clean portal to see key fund metrics and download relevant documents — on their time, not the GP’s.
Communication became tailored: Whether the LP is a biotech expert or a generalist allocator, the right level of information reaches the right person.
Time was given back: The team now spends less time formatting and chasing down document requests — and more time preparing strategic updates.
Before Vessel
Manual report distribution via email
Repetitive questions from LPs about missing info
Hours spent sorting which documents go to which LP role
Reporting felt “pushed” from the GP side
Reporting felt “pushed” from the GP side
After Vessel
LPs access all reports securely in a self-serve portal
Fewer inbound requests thanks to real-time access
Documents auto-tagged and filtered by role (IR, tax, legal)
Dynamic experience with fund metrics and structured updates
LPs can pull what they need, when they need it
“Vessel has become an extension of our LP experience — not just a reporting tool, but a partner in how we build trust.”
Here’s why Genesys would recommend Vessel to other emerging or established GPs:
Blazing-fast onboarding, even in the middle of a fund cycle
Vessel’s AI file organizer eliminates manual folder sorting and tagging
LPs love the experience — calling it “slick,” “easy,” and “intuitive”
Dedicated WhatsApp channel made the Vessel team reachable 24/7 for anything we needed
The Vessel team feels like an extension of ours — responsive, thoughtful, and product-forward.
Whether you’re managing three funds or scaling to seven, Vessel adapts to your stack — and upgrades the LP experience from day one.
Communicating the progress of early-stage biotech companies isn’t easy — especially when LPs vary in their scientific background.
Some LPs want scientific depth. Others want clean metrics. Vessel gives Genesys the ability to meet both expectations without compromising clarity or polish.
Vessel gave Genesys the ability to:
Customize what information gets emphasized
Provide context around portfolio progress
Balance deep science with intuitive data presentation
A Foundation for the Next Decade
Genesys sees Vessel not just as a reporting tool, but a foundation for the future:
They plan to expand its use for fundraising, onboarding, and subscriptions
They’re investing in the next generation of GPs — who will expect this level of tooling
They’re focused on keeping LP relationships strong, simple, and scalable
